Skip to main content

Welcome to Enterra Medical’s educational resource center

The Enterra Therapy System eLearning Training Course will provide you with foundational knowledge on gastroparesis and the Enterra Therapy System. 

Educational videos

Gastroparesis: Diagnosing and Treating

Discover the fundamentals of gastroparesis, including its symptoms, diagnostic processes, and treatment options. Our videos provide detailed explanations from medical experts, helping you gain a clearer understanding of this chronic condition and the available therapeutic approaches.

Enterra Therapy Patient Selection

Selecting the right patients for Enterra Therapy is crucial for optimal outcomes. Our educational videos guide you through the criteria and considerations for patient selection, ensuring that you have the knowledge to identify candidates who may benefit most from this advanced gastroparesis treatment.

Enterra Therapy Procedure

Gain insight into the Enterra Therapy procedure. From pre-operative preparations to the surgical implantation of the Enterra device, our content is designed to provide a thorough understanding of the implant procedure.

Device Programming and Post-Operative Management

Proper device programming and effective post-operative management are essential. Our videos cover the intricacies of device programming, troubleshooting, and long-term management strategies, helping you ensure the best possible outcomes for your patients.

Clinical Evidence

Explore key clinical studies evaluating Enterra® Therapy in treating diabetic and idiopathic gastroparesis. These videos highlight significant improvements in nausea and vomiting symptoms, supported by clinical research.

Evolutions in Gastroparesis and Gastric Electrical Stimulation: The past, present and future

A multi-part video series to help you gain insights into gastroparesis and gastric electrical stimulation.

At Enterra Medical, we are dedicated to providing valuable resources to help you understand and effectively utilize Enterra Therapy for managing gastroparesis. Our collection of educational videos offers insights and guidance for healthcare professionals. From patient selection to the intricacies of the therapy procedure, device programming, and post-operative management, our videos are designed to ensure you have the knowledge and skills necessary to achieve the best outcomes with Enterra Therapy.

From Data to Practice: Crafting Effective Clinical Protocols and Partnerships for Gastroparesis Management

(1:04:56)

Camille Thélin M.D., M.Sc.
Bailey Blankenship MSN, APRN, FNP-C

Gastroparesis: Diagnosis and Treatment Options

(1:19:30)

Diana McFarlane, PA-C

Gastroparesis: Case Studies

(0:16:29)

Diana McFarlane, PA-C
Chanil Jeffreys, FNP, DNP, JD

Best Practices in Patient Selection and Management of Gastroparesis Patients

(0:29:27)

Dr. Reena Chokshi

Device Programming and Post-Operative Management

(0:34:26)

Diana McFarlane, PA-C

Enterra Programming Case Studies

(0:29:32)

Diana McFarlane, PA-C

A Multi-Disciplinary Approach Provides Optimism for Patients Living with Gastroparesis

(0:59:50)

Michael M. Awad, MD, PhD, MHPE, FACS, FAFS

Tell me about the surgical options you consider once conservative therapy has failed and why…

(0:1:53)

Reena Chokshi, MD
Joseph Sujka, MD

Tell me about gastric electrical stimulation (GES) and where it benefits patients most…

(0:5:40)

Reena Chokshi, MD
Joseph Sujka, MD

Tell me about current data on GES and what it means for patient care…

(0:4:10)

Reena Chokshi, MD
Joseph Sujka, MD

Tell me about how you counsel your patients on the long-term efficacy of various gastroparesis treatments…

(0:5:41)

Reena Chokshi, MD
Joseph Sujka, MD

IMPORTANT SAFETY INFORMATION

Enterra Therapy for treatment of chronic, resistant to medication nausea and vomiting associated with gastroparesis caused by diabetes or an unknown origin in patients aged 18 to 70 years: patients should always discuss potential risks and benefits of the device with their physician.

HUMANITARIAN DEVICE

Authorized by Federal law for use in the treatment of chronic intractable (drug refractory) nausea and vomiting secondary to gastroparesis of diabetic or idiopathic etiology in patients aged 18 to 70 years. The effectiveness of this device for this use has not been demonstrated. What does this mean?